VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations
Implementing VA-Comm was feasible, and participants held positive views on the usefulness and ease of use. VA-Comm can serve as a framework for improving communication in other serious illnesses.
Authors
- Bryan A. Sisk (ORCID: https://orcid.org/0000-0002-2456-2476)
- Alexandra J. Borst (ORCID: https://orcid.org/0000-0002-7316-8643)
- Maura M. Kepper (ORCID: https://orcid.org/0000-0002-5971-9189)
- Stefanie N. Milam (ORCID: https://orcid.org/0000-0001-7694-4129)
- Christine Bereitschaft (ORCID: https://orcid.org/0000-0003-1336-9643)
- Anna M. Kerr (ORCID: https://orcid.org/0000-0002-4778-8515)
- Taizo A. Nakano (ORCID: https://orcid.org/0000-0003-0389-2297)
- Melinda Wu (ORCID: https://orcid.org/0009-0007-9649-5771)
- Stephanie Chen
Institutions
- University of North Carolina at Chapel Hill (US)
- Washington University in St. Louis (US)
- Children's Hospital Colorado (US)
- Doernbecher Children's Hospital (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1002/pbc.32149
- Primary Topic
- Patient-Provider Communication in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00